Skip to content
Archive of posts filed under the arthritis news category.

UNC Helps Establish The First National Public Health Agenda For Osteoarthritis

Betty Isaacs of Boone, N.C., knows all about the chronic pain of osteoarthritis and the impact it has on her life. “The pain in my knee was so bad, I would just sit around,” Isaacs said. Last year, Isaacs participated in the Walk with Ease program administered through the UNC Thurston Arthritis Research Center and developed by the Arthritis Foundation…

Orthopedic Research Society Honor BIDMC Scientist

Christopher Evans, PhD, director of the Center for Advanced Orthopaedic Studies at Beth Israel Deaconess Medical Center (BIDMC) and Maurice Edmond Mueller Professor of Orthopaedic Surgery at Harvard Medical School, were presented with the 2010 Arthur Steindler Award at this week’s annual meeting of the Orthopaedic Research Society in New Orleans…

Differing Patient And Doctor Expectations From Joint Replacement Surgeries

While physicians strive to set realistic expectations for patients undergoing knee and hip joint replacements, a new study reveals that doctor and patient expectations are sometimes not aligned…

Pain Relief For Osteoarthritis Provided By Electromagnetic Pulses

Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers…

NICE Asks For More Data On New Drug For Rheumatoid Arthritis

NICE’s independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product…

NICE Reassessment Of Switching Decision Brings Little Hope For Rheumatoid Arthritis Patients

The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE’s provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS’s successful appeal of negative NICE guidance on switching in 2007…